A hacking group has reportedly breached the security of Novo Nordisk, a major pharmaceutical company, and is demanding a ransom of $25 million. This incident highlights the growing vulnerabilities within corporate cybersecurity frameworks.
The group, which has not been named, claims to have accessed sensitive data during the hack. Novo Nordisk, known for its diabetes care products, has yet to confirm the breach details or its response strategy.
As of now, the company is assessing the situation and working with cybersecurity experts. The potential impact on operations and patient safety remains unclear, but the incident raises concerns about data protection in the industry.